BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23866604)

  • 1. [Factors for the development and progression of cardiorenal complications in women].
    Chicherina EN; Padyganova AV
    Ter Arkh; 2013; 85(6):85-9. PubMed ID: 23866604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
    Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
    J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetic nephropathy: new insights into diagnosis, prevention and treatment].
    Rheinberger M; Böger CA
    Dtsch Med Wochenschr; 2014 Apr; 139(14):704-6. PubMed ID: 24668430
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic renal insufficiency and cardiovascular disease].
    Charriere S; Rognant N; Chiche F; Cremer A; Deray G; Priou M
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):40-52. PubMed ID: 18937921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting, preventing, and managing cardiovascular and chronic kidney disease progression in people with type 2 diabetes: How to improve on traditional strategies.
    Weir MR
    J Diabetes; 2019 Jul; 11(7):619-622. PubMed ID: 31066238
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference.
    McCullough PA; Haapio M; Mankad S; Zamperetti N; Massie B; Bellomo R; Berl T; Anker SD; Anand I; Aspromonte N; Bagshaw SM; Bobek I; Cruz DN; Daliento L; Davenport A; Hillege H; House AA; Katz N; Maisel A; Mebazaa A; Palazzuoli A; Ponikowski P; Ronco F; Shaw A; Sheinfeld G; Soni S; Vescovo G; Zanco P; Ronco C; Berl T;
    Nephrol Dial Transplant; 2010 Jun; 25(6):1777-84. PubMed ID: 20375030
    [No Abstract]   [Full Text] [Related]  

  • 7. Preclinical cardiovascular abnormalities in patients in early stages of renal disease without nephrotic syndrome.
    Esposito P; Palmieri V; Migliaresi P; Pezzullo S; Martino S; Balletta MM
    Hypertens Res; 2009 Dec; 32(12):1155-6. PubMed ID: 19851328
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preeclampsia (marker of chronic kidney disease): from genesis to future risks.
    Facca TA; Kirsztajn GM; Sass N
    J Bras Nefrol; 2012 Mar; 34(1):87-93. PubMed ID: 22441189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systematic approach to organ-specific complications after allogeneic hematopoietic cell transplantation].
    Ichinohe T
    Rinsho Ketsueki; 2014 Oct; 55(10):2125-35. PubMed ID: 25297779
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: data from the Italy - Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study.
    Sciarretta S; Valenti V; Tocci G; Pontremoli R; Rosei EA; Ambrosioni E; Costa V; Leonetti G; Pessina AC; Trimarco B; Chin D; Paneni F; Deferrari G; Ferrucci A; Volpe M
    J Hypertens; 2010 Feb; 28(2):251-8. PubMed ID: 19812502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can changing antihypertensive administration time alone reduce the risk for CVD in nondipper patients with CKD?
    Fukuda M
    Am J Kidney Dis; 2008 Jul; 52(1):193; author reply 193-4. PubMed ID: 18589219
    [No Abstract]   [Full Text] [Related]  

  • 13. The importance of cardiovascular disease in pediatric transplantation and its link to the kidneys.
    Johnson JN; Filler G
    Pediatr Transplant; 2018 May; 22(3):e13146. PubMed ID: 29441655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension in moderate-to-severe nondiabetic CKD patients.
    Segura J; Ruilope LM
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):23-7. PubMed ID: 21224027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and renal complications.
    Greathouse MK; Weir MR
    Postgrad Med; 2012 Mar; 124(2):40-52. PubMed ID: 22437214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension in pregnant women--a novel cardiorenal continuum].
    Gaĭsin IR
    Ter Arkh; 2012; 84(1):48-53. PubMed ID: 22616532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of chronic kidney disease in Italy: the CARHES study].
    De Nicola L; Dal Canton A;
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):106S-108S. PubMed ID: 20879494
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypertension and renal disease].
    Kamper AL; Pedersen EB; Strandgaard S
    Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of kidney insufficiency in primary care population in Spain: EROCAP study].
    de Francisco AL; De la Cruz JJ; Cases A; de la Figuera M; Egocheaga MI; Górriz JI; Llisterri JI; Marín R; Martínez Castelao A
    Nefrologia; 2007; 27(3):300-12. PubMed ID: 17725449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.